New methods for finding common insertion sites and co-occurring common insertion sites in transposon-and virus-based genetic screens

Nucleic Acids Research

Volumn 40, Issue 9, 2012, Pages 3822-3833

  Bergemann, Tracy L ^a,f   Starr, Timothy K ^b,c   Yu, Haoyu ^c   Steinbach, Michael ^c   Erdmann, Jesse ^c   Chen, Yun ^d   Cormier, Robert T ^e   Largaespada, David A ^c   Silverstein, Kevin A T ^c  

^a School of Public Health   (United States)

^b Gynecology and Women's Health   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d Opera Solutions   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f Medtronic Cardiac Rhythm Disease Management   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; COMMON COOCCURRING INSERTION SITE; COMMON INSERTION SITE; CONTROLLED STUDY; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INSERTION; GENE INSERTION SEQUENCE; GENE LOCATION; GENE MUTATION; GENETIC DATABASE; GENETIC MODEL; GENETIC SCREENING; INTERMETHOD COMPARISON; MONTE CARLO METHOD; MOUSE; NONHUMAN; PERSONALIZED MEDICINE; POISSON DISTRIBUTION; POISSON REGRESSION INSERTION MODEL; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RETROVIRAL TAGGED CANCER GENE DATABASE; RETROVIRUS; SINGLE CELL ANALYSIS; TRANSPOSON; TUMOR GENE; TUMOR GROWTH; VIRUS;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DNA TRANSPOSABLE ELEMENTS; GASTROINTESTINAL NEOPLASMS; GENES, NEOPLASM; HUMANS; MICE; MONTE CARLO METHOD; MUTAGENESIS, INSERTIONAL; POISSON DISTRIBUTION; REGRESSION ANALYSIS; RETROVIRIDAE;

MUS;

EID: 84861407502     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr1295     Document Type: Article

References (44)

1. Ashley, D.J. (1969) The two "hit" and multiple "hit" theories of carcinogenesis. Br. J. Cancer, 23, 313-328.
2. Knudson, A.G. (1971) Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci., 68, 820-823.
3. Knudson, A.G. (2001) Two genetic hits (more or less) to cancer. Nat. Rev. Cancer Sci., 1, 157-162. (Pubitemid 33741891)
4. Fearon, E.R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
5. Hanahan, D. and Weinberg, R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70. (Pubitemid 30046295)
6. Collier, L.S., Carlson, C.M., Ravimohan, S., Dupuy, A.J. and Largaespada, D.A. (2005) Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature, 436, 272-276. (Pubitemid 41021279)
7. Dupuy, A.J., Akagi, K., Largaespada, D.A., Copeland, N.G. and Jenkins, N.A. (2005) Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature, 436, 221-226. (Pubitemid 41021267)
8. Dupuy, A.J., Rogers, L.M., Kim, J., Nannapaneni, K., Starr, T.K., Liu, P., Largaespada, D.A., Scheetz, T.E., Jenkins, N.A. and Copeland, N.G. (2009) A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res., 69, 8150-8156.
9. Keng, V.W., Villanueva, A., Chiang, D.Y., Dupuy, A.J., Ryan, B.J., Matise, I., Silverstein, K.A., Sarver, A., Starr, T.K., Akagi, K. et al. (2009) A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat. Biotechnol., 27, 264-274.
10. Starr, T.K., Allaei, R., Silverstein, K.A., Staggs, R.A., Bergemann, T.L., O'Sullivan, M.G., Matise, I., Dupuy, A.J., Collier, L.S., Powers, S. et al. (2009) A transposon-based genetic screen identifies genes altered in colorectal cancer. Science, 323, 1747-1750.
11. Uren, A.G., Kool, J., Berns, A. and van Lohuizen, M. (2005) Retroviral insertional mutagenesis: past, present and future. Oncogene, 24, 7656-7672. (Pubitemid 41670669)
12. Mikkers, H., Allen, J., Knipscheer, P., Romeijn, L., Hart, A., Vink, E. and Berns, A. (2002) High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat. Genet., 32, 153-159. (Pubitemid 34977211)
13. de Ridder, J., Uren, A., Kool, J., Reinders, M. and Wessels, L. (2006) Detecting statistically significant common insertion sites in retroviral insertional mutagenesis screens. PLoS Comput. Biol., 2, e166.
14. de Ridder, J., Kool, J., Uren, A., Bot, J., Wessels, L. and Reinders, M. (2007) Co-occurrence analysis of insertional mutagenesis data reveals cooperating oncogenes. Bioinformatics, 23, i133-i141. (Pubitemid 47244394)
15. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R Stat. Soc. Series B Stat. Methodol., 57, 289-300.
16. Ferriera, J.A. and Zwinderman, A.H. (2006) On the Benjamini-Hochberg Method. Ann. Stat., 34, 1827-1849. (Pubitemid 44875083)
17. Ivics, Z., Hackett, P.B., Plasterk, R.H. and Izsvák, Z. (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell, 91, 501-510. (Pubitemid 27508239)
18. Huss, J.W. III, Lindenbaum, P., Martone, M., Roberts, D., Pizarro, A., Valafar, F., Hogenesch, J.B. and Su, A.I. (2010) The Gene Wiki: community intelligence applied to human gene annotation. Nucleic Acids Res., 38, D633-D639.
19. Goeman, J.J., van de Geer, S.A., de Kort, F. and van Houwelingen, H.C. (2004) A global test for groups of genes: testing association with a clinical outcome. Bioinformatics, 20, 93-99. (Pubitemid 38088346)
20. Ki, D.H., Jeung, H.C., Park, C.H., Kang, S.H., Lee, G.Y., Lee, W.S., Kim, N.K., Chung, H.C. and Rha, S.Y. (2007) Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int. J. Cancer, 121, 2005-2012.
21. Futreal, P.A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N. and Stratton, M.R. (2004) A census of human cancer genes. Nat. Rev. Cancer, 4, 177-183. (Pubitemid 38337497)
22. Wood, L.D., Parsons, D.W., Jones, S., Lin, J., Sjoblom, T., Leary, R.J., Shen, D., Boca, S.M., Barber, T., Ptak, J. et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science, 318, 1108-1113. (Pubitemid 350134889)
23. Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S.M., Riggins, G.J. et al. (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science, 304, 554. (Pubitemid 38541907)
24. Parsons, D.W., Wang, T.L., Samuels, Y., Bardelli, A., Cummins, J.M., DeLong, L., Silliman, N., Ptak, J., Szabo, S., Willson, J.K. et al. (2005) Colorectal cancer: mutations in a signalling pathway. Nature, 436, 792. (Pubitemid 41160630)
25. Samuels, Y., Diaz, L.A. Jr, Schmidt-Kittler, O., Cummins, J.M., Delong, L., Cheong, I., Rago, C., Huso, D.L., Lengauer, C., Kinzler, K.W. et al. (2005) Mutant PIK3CA promotes cells growth and invasion of human cancer cells. Cancer Cell, 7, 561-573. (Pubitemid 40799249)
26. Sartore-Bianchi, A., Martini, M., Molinari, F., Veronese, S., Nichelatti, M., Artale, S., Di Nicolantonio, F., Saletti, P., De Dosso, S., Mazzucchelli, L. et al. (2009) PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies. Cancer Res., 69, 1851-1857.
27. Clevers, H. and Batlle, E. (2006) EphB/EphrinB receptors and Wnt signaling in colorectal cancer. Cancer Res., 66, 2-5. (Pubitemid 43165998)
28. Zogopoulos, G., Jorgensen, C., Bacani, J., Montpetit, A., Lepage, P., Ferretti, V., Chad, L., Selvarajah, S., Zanke, B., Hudson, T.J. et al. (2008) Germline EPHB2 receptor variants in familial colorectal cancer. PLoS One, 3, e2885.
29. Forgue-Lafitte, M.E., Fabiani, B., Levy, P.P., Maurin, N., Fléjou, J.F. and Bara, J. (2007) Abnormal expression of M1/MUC5AC mucin in distal colon of patients with diverticulitis, ulcerative colitis and cancer. Int. J. Cancer, 121, 1543-1549. (Pubitemid 47328714)
30. Nieuwenhuis, M.H., Mathus-Vliegen, L.M., Slors, F.J., Griffioen, G., Nagengast, F.M., Schouten, W.R., Kleibeuker, J.H. and Vasen, H.F. (2007) Genotype-phenotype correlations as a guide in the management of familial adenomatous polyposis. Clin. Gastroenterol. Hepatol., 5, 374-378. (Pubitemid 46401526)
31. Fodde, R. (2002) The APC gene in colorectal cancer. Eur. J. Cancer, 38, 867-871. (Pubitemid 34442313)
32. Bell, S.M., Schreiner, C.M., Wert, S.E., Mucenski, M.L., Scott, W.J. and Whitsett, J.A. (2008) R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis. Development, 135, 1049-1058. (Pubitemid 351578133)
33. Kazanskaya, O., Glinka, A., del Barco Barrantes, I., Stannek, P., Niehrs, C. and Wu, W. (2004) R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis. Dev. Cell, 7, 525-534. (Pubitemid 39341838)
34. Nam, J.S., Park, E., Turcotte, T.J., Palencia, S., Zhan, X., Lee, J., Yun, K., Funk, W.D. and Yoon, J.K. (2007) Mouse R-spondin2 is required for apical ectodermal ridge maintenance in the hindlimb. Dev. Biol., 311, 124-135. (Pubitemid 47588235)
35. Yamada, W., Nagao, K., Horikoshi, K., Fujikura, A., Ikeda, E., Inagaki, Y., Kakitani, M., Tomizuka, K., Miyazaki, H., Suda, T. et al. (2009) Craniofacial malformation in R-spondin2 knockout mice. Biochem. Biophys. Res. Commun., 381, 453-458.
36. Kim, K.A., Kakitani, M., Zhao, J., Oshima, T., Tang, T., Binnerts, M., Liu, Y., Boyle, B., Park, E., Emtage, P. et al. (2005) Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science, 309, 1256-1259. (Pubitemid 41170922)
37. Sugiura, T., Noguchi, Y., Sakurai, K. and Hattori, C. (2008) Protein phosphatase 1H, overexpressed in colon adenocarcinoma, is associated with CSE1L. Cancer Biol. Ther., 7, 285-292. (Pubitemid 351590438)
38. Tanaka, T., Ohkubo, S., Tatsuno, I. and Prives, C. (2007) hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes. Cell, 130, 638-650. (Pubitemid 47268061)
39. Scherf, U., Kalab, P., Dasso, M., Pastan, I. and Brinkmann, U. (1998) The hCSE1/CAS protein is phosphorylated by HeLa extracts and MEK-1: MEK-1 phosphorylation may modulate the intracellular localization of CAS. Biochem. Biophys. Res. Commun., 250, 623-628. (Pubitemid 28484778)
40. Hu, M., Yang, J.L., Teng, H., Jia, Y.Q., Wang, R., Zhang, X.W., Wu, Y., Luo, Y., Chen, X.C., Zhang, R. et al. (2008) Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model. BMC Cancer, 8, 306.
41. Kumar, H., Heer, K., Greenman, J., Kerin, M.J. and Monson, J.R. (2002) Soluble FLT-1 is detectable in the sera of colorectal and breast cancer patients. Anticancer Res., 22, 1877-1880. (Pubitemid 34839213)
42. Harris, A.L., Reusch, P., Barleon, B., Hang, C., Dobbs, N. and Marme, D. (2001) Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy. Clin. Cancer Res., 7, 1992-1997. (Pubitemid 32994837)
43. Moran, A.E., Hunt, D.H., Javid, S.H., Redston, M., Carothers, A.M. and Bertagnolli, M.M. (2004) Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+mice. J. Biol. Chem., 279, 43261-43272. (Pubitemid 39372222)
44. Flicek, P., Aken, B.L., Beal, K., Ballester, B., Caccamo, M., Chen, Y., Clarke, L., Coates, G., Cunningham, F., Cutts, T. et al. (2008) Ensembl 2008. Nucleic Acids Res., 36, D707-D714. (Pubitemid 351149811)